Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 8,477.00
-23.00 (-0.27%)
Aug 14, 2026, 3:15 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.25 trillion as of August 14, 2026. Its market cap has increased by 38.96% in one year.
Market Cap
2.25T
Enterprise Value
2.22T
Revenue
112.30B
Ranking
n/a
PE Ratio
76.91
Stock Price
8,477.00
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.25T, an increase of 110,455.61%. That is a compound annual growth rate of 34.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.25T | 32.61% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.63T |
| Cipla | 1.17T |
| Zydus Lifesciences | 1.13T |
| Mankind Pharma | 1.00T |
| Laurus Labs | 964.89B |
| Aurobindo Pharma | 933.32B |
| Glenmark Pharmaceuticals | 654.25B |
| Alkem Laboratories | 641.82B |